Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors customize treatment to individual patient needs. Personalized treatments may cause fewer side effects than standard options. Some people are already benefiting from this approach.

Market Analysis and Insights: Global Personalized Cancer Medicine Market

The global Personalized Cancer Medicine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Personalized Cancer Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Personalized Cancer Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Personalized Cancer Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Personalized Cancer Medicine include Abbott, Merck, Novartis, Amgen, Celgene, Bayer, Roche, Astellas and Astrazeneca, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Personalized Cancer Medicine is widely used in various fields, such as Breast Cancer, Lung Cancer, Chronic Myeloid Leukaemia and Bowel Cancer, etc. Breast Cancer provides greatest supports to the Personalized Cancer Medicine industry development. In 2023, global % revenue of Personalized Cancer Medicine went into Breast Cancer filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Personalized Cancer Medicine market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Personalized Cancer Medicine, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Personalized Cancer Medicine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Personalized Cancer Medicine revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Personalized Cancer Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Personalized Cancer Medicine revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Personalized Cancer Medicine Market Report

Report Metric	Details
Report Name	Personalized Cancer Medicine Market
Segment by Type	Monoclonal Antibodies Personalized Cancer Vaccines Other
Segment by Application	Breast Cancer Lung Cancer Chronic Myeloid Leukaemia Bowel Cancer Other Cancer
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Merck, Novartis, Amgen, Celgene, Bayer, Roche, Astellas, Astrazeneca, Johnson & Johnson, Agilent, Takeda
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Personalized Cancer Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Cancer Medicine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Personalized Cancer Medicine revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Personalized Cancer Medicine Market report?

Ans: The main players in the Personalized Cancer Medicine Market are Abbott, Merck, Novartis, Amgen, Celgene, Bayer, Roche, Astellas, Astrazeneca, Johnson & Johnson, Agilent, Takeda

What are the Application segmentation covered in the Personalized Cancer Medicine Market report?

Ans: The Applications covered in the Personalized Cancer Medicine Market report are Breast Cancer, Lung Cancer, Chronic Myeloid Leukaemia, Bowel Cancer, Other Cancer

What are the Type segmentation covered in the Personalized Cancer Medicine Market report?

Ans: The Types covered in the Personalized Cancer Medicine Market report are Monoclonal Antibodies, Personalized Cancer Vaccines, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Personalized Cancer Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Monoclonal Antibodies

1.2.3 Personalized Cancer Vaccines

1.2.4 Other

1.3 Market by Application

1.3.1 Global Personalized Cancer Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Breast Cancer

1.3.3 Lung Cancer

1.3.4 Chronic Myeloid Leukaemia

1.3.5 Bowel Cancer

1.3.6 Other Cancer

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Personalized Cancer Medicine Market Perspective (2019-2030)

2.2 Global Personalized Cancer Medicine Growth Trends by Region

2.2.1 Personalized Cancer Medicine Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Personalized Cancer Medicine Historic Market Size by Region (2019-2024)

2.2.3 Personalized Cancer Medicine Forecasted Market Size by Region (2025-2030)

2.3 Personalized Cancer Medicine Market Dynamics

2.3.1 Personalized Cancer Medicine Industry Trends

2.3.2 Personalized Cancer Medicine Market Drivers

2.3.3 Personalized Cancer Medicine Market Challenges

2.3.4 Personalized Cancer Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Personalized Cancer Medicine by Players

3.1.1 Global Personalized Cancer Medicine Revenue by Players (2019-2024)

3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Players (2019-2024)

3.2 Global Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Personalized Cancer Medicine, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Personalized Cancer Medicine Market Concentration Ratio

3.4.1 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Medicine Revenue in 2023

3.5 Global Key Players of Personalized Cancer Medicine Head office and Area Served

3.6 Global Key Players of Personalized Cancer Medicine, Product and Application

3.7 Global Key Players of Personalized Cancer Medicine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Cancer Medicine Breakdown Data by Type

4.1 Global Personalized Cancer Medicine Historic Market Size by Type (2019-2024)

4.2 Global Personalized Cancer Medicine Forecasted Market Size by Type (2025-2030)

5 Personalized Cancer Medicine Breakdown Data by Application

5.1 Global Personalized Cancer Medicine Historic Market Size by Application (2019-2024)

5.2 Global Personalized Cancer Medicine Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Personalized Cancer Medicine Market Size (2019-2030)

6.2 North America Personalized Cancer Medicine Market Size by Type

6.2.1 North America Personalized Cancer Medicine Market Size by Type (2019-2024)

6.2.2 North America Personalized Cancer Medicine Market Size by Type (2025-2030)

6.2.3 North America Personalized Cancer Medicine Market Share by Type (2019-2030)

6.3 North America Personalized Cancer Medicine Market Size by Application

6.3.1 North America Personalized Cancer Medicine Market Size by Application (2019-2024)

6.3.2 North America Personalized Cancer Medicine Market Size by Application (2025-2030)

6.3.3 North America Personalized Cancer Medicine Market Share by Application (2019-2030)

6.4 North America Personalized Cancer Medicine Market Size by Country

6.4.1 North America Personalized Cancer Medicine Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Personalized Cancer Medicine Market Size by Country (2019-2024)

6.4.3 North America Personalized Cancer Medicine Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Personalized Cancer Medicine Market Size (2019-2030)

7.2 Europe Personalized Cancer Medicine Market Size by Type

7.2.1 Europe Personalized Cancer Medicine Market Size by Type (2019-2024)

7.2.2 Europe Personalized Cancer Medicine Market Size by Type (2025-2030)

7.2.3 Europe Personalized Cancer Medicine Market Share by Type (2019-2030)

7.3 Europe Personalized Cancer Medicine Market Size by Application

7.3.1 Europe Personalized Cancer Medicine Market Size by Application (2019-2024)

7.3.2 Europe Personalized Cancer Medicine Market Size by Application (2025-2030)

7.3.3 Europe Personalized Cancer Medicine Market Share by Application (2019-2030)

7.4 Europe Personalized Cancer Medicine Market Size by Country

7.4.1 Europe Personalized Cancer Medicine Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Personalized Cancer Medicine Market Size by Country (2019-2024)

7.4.3 Europe Personalized Cancer Medicine Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Personalized Cancer Medicine Market Size (2019-2030)

8.2 China Personalized Cancer Medicine Market Size by Type

8.2.1 China Personalized Cancer Medicine Market Size by Type (2019-2024)

8.2.2 China Personalized Cancer Medicine Market Size by Type (2025-2030)

8.2.3 China Personalized Cancer Medicine Market Share by Type (2019-2030)

8.3 China Personalized Cancer Medicine Market Size by Application

8.3.1 China Personalized Cancer Medicine Market Size by Application (2019-2024)

8.3.2 China Personalized Cancer Medicine Market Size by Application (2025-2030)

8.3.3 China Personalized Cancer Medicine Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Personalized Cancer Medicine Market Size (2019-2030)

9.2 Asia Personalized Cancer Medicine Market Size by Type

9.2.1 Asia Personalized Cancer Medicine Market Size by Type (2019-2024)

9.2.2 Asia Personalized Cancer Medicine Market Size by Type (2025-2030)

9.2.3 Asia Personalized Cancer Medicine Market Share by Type (2019-2030)

9.3 Asia Personalized Cancer Medicine Market Size by Application

9.3.1 Asia Personalized Cancer Medicine Market Size by Application (2019-2024)

9.3.2 Asia Personalized Cancer Medicine Market Size by Application (2025-2030)

9.3.3 Asia Personalized Cancer Medicine Market Share by Application (2019-2030)

9.4 Asia Personalized Cancer Medicine Market Size by Region

9.4.1 Asia Personalized Cancer Medicine Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Personalized Cancer Medicine Market Size by Region (2019-2024)

9.4.3 Asia Personalized Cancer Medicine Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Type

10.2.1 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Application

10.3.1 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country

10.4.1 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Personalized Cancer Medicine Introduction

11.1.4 Abbott Revenue in Personalized Cancer Medicine Business (2019-2024)

11.1.5 Abbott Recent Developments

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Personalized Cancer Medicine Introduction

11.2.4 Merck Revenue in Personalized Cancer Medicine Business (2019-2024)

11.2.5 Merck Recent Developments

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Personalized Cancer Medicine Introduction

11.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2019-2024)

11.3.5 Novartis Recent Developments

11.4 Amgen

11.4.1 Amgen Company Details

11.4.2 Amgen Business Overview

11.4.3 Amgen Personalized Cancer Medicine Introduction

11.4.4 Amgen Revenue in Personalized Cancer Medicine Business (2019-2024)

11.4.5 Amgen Recent Developments

11.5 Celgene

11.5.1 Celgene Company Details

11.5.2 Celgene Business Overview

11.5.3 Celgene Personalized Cancer Medicine Introduction

11.5.4 Celgene Revenue in Personalized Cancer Medicine Business (2019-2024)

11.5.5 Celgene Recent Developments

11.6 Bayer

11.6.1 Bayer Company Details

11.6.2 Bayer Business Overview

11.6.3 Bayer Personalized Cancer Medicine Introduction

11.6.4 Bayer Revenue in Personalized Cancer Medicine Business (2019-2024)

11.6.5 Bayer Recent Developments

11.7 Roche

11.7.1 Roche Company Details

11.7.2 Roche Business Overview

11.7.3 Roche Personalized Cancer Medicine Introduction

11.7.4 Roche Revenue in Personalized Cancer Medicine Business (2019-2024)

11.7.5 Roche Recent Developments

11.8 Astellas

11.8.1 Astellas Company Details

11.8.2 Astellas Business Overview

11.8.3 Astellas Personalized Cancer Medicine Introduction

11.8.4 Astellas Revenue in Personalized Cancer Medicine Business (2019-2024)

11.8.5 Astellas Recent Developments

11.9 Astrazeneca

11.9.1 Astrazeneca Company Details

11.9.2 Astrazeneca Business Overview

11.9.3 Astrazeneca Personalized Cancer Medicine Introduction

11.9.4 Astrazeneca Revenue in Personalized Cancer Medicine Business (2019-2024)

11.9.5 Astrazeneca Recent Developments

11.10 Johnson & Johnson

11.10.1 Johnson & Johnson Company Details

11.10.2 Johnson & Johnson Business Overview

11.10.3 Johnson & Johnson Personalized Cancer Medicine Introduction

11.10.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2019-2024)

11.10.5 Johnson & Johnson Recent Developments

11.11 Agilent

11.11.1 Agilent Company Details

11.11.2 Agilent Business Overview

11.11.3 Agilent Personalized Cancer Medicine Introduction

11.11.4 Agilent Revenue in Personalized Cancer Medicine Business (2019-2024)

11.11.5 Agilent Recent Developments

11.12 Takeda

11.12.1 Takeda Company Details

11.12.2 Takeda Business Overview

11.12.3 Takeda Personalized Cancer Medicine Introduction

11.12.4 Takeda Revenue in Personalized Cancer Medicine Business (2019-2024)

11.12.5 Takeda Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Personalized Cancer Medicine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Personalized Cancer Vaccines

Table 4. Key Players of Other

Table 5. Global Personalized Cancer Medicine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Personalized Cancer Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Personalized Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Personalized Cancer Medicine Market Share by Region (2019-2024)

Table 9. Global Personalized Cancer Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Personalized Cancer Medicine Market Share by Region (2025-2030)

Table 11. Personalized Cancer Medicine Market Trends

Table 12. Personalized Cancer Medicine Market Drivers

Table 13. Personalized Cancer Medicine Market Challenges

Table 14. Personalized Cancer Medicine Market Restraints

Table 15. Global Personalized Cancer Medicine Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Personalized Cancer Medicine Revenue Share by Players (2019-2024)

Table 17. Global Top Personalized Cancer Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2023)

Table 18. Global Personalized Cancer Medicine Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Personalized Cancer Medicine Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Personalized Cancer Medicine, Headquarters and Area Served

Table 21. Global Key Players of Personalized Cancer Medicine, Product and Application

Table 22. Global Key Players of Personalized Cancer Medicine, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Personalized Cancer Medicine Revenue Market Share by Type (2019-2024)

Table 26. Global Personalized Cancer Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Personalized Cancer Medicine Revenue Market Share by Type (2025-2030)

Table 28. Global Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Personalized Cancer Medicine Revenue Share by Application (2019-2024)

Table 30. Global Personalized Cancer Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Personalized Cancer Medicine Revenue Share by Application (2025-2030)

Table 32. North America Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Personalized Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Personalized Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Personalized Cancer Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Personalized Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Personalized Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Personalized Cancer Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Personalized Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Personalized Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Personalized Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Personalized Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Personalized Cancer Medicine Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Personalized Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Personalized Cancer Medicine Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Personalized Cancer Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 64. Abbott Company Details

Table 65. Abbott Business Overview

Table 66. Abbott Personalized Cancer Medicine Product

Table 67. Abbott Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 68. Abbott Recent Developments

Table 69. Merck Company Details

Table 70. Merck Business Overview

Table 71. Merck Personalized Cancer Medicine Product

Table 72. Merck Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 73. Merck Recent Developments

Table 74. Novartis Company Details

Table 75. Novartis Business Overview

Table 76. Novartis Personalized Cancer Medicine Product

Table 77. Novartis Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 78. Novartis Recent Developments

Table 79. Amgen Company Details

Table 80. Amgen Business Overview

Table 81. Amgen Personalized Cancer Medicine Product

Table 82. Amgen Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 83. Amgen Recent Developments

Table 84. Celgene Company Details

Table 85. Celgene Business Overview

Table 86. Celgene Personalized Cancer Medicine Product

Table 87. Celgene Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 88. Celgene Recent Developments

Table 89. Bayer Company Details

Table 90. Bayer Business Overview

Table 91. Bayer Personalized Cancer Medicine Product

Table 92. Bayer Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 93. Bayer Recent Developments

Table 94. Roche Company Details

Table 95. Roche Business Overview

Table 96. Roche Personalized Cancer Medicine Product

Table 97. Roche Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 98. Roche Recent Developments

Table 99. Astellas Company Details

Table 100. Astellas Business Overview

Table 101. Astellas Personalized Cancer Medicine Product

Table 102. Astellas Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 103. Astellas Recent Developments

Table 104. Astrazeneca Company Details

Table 105. Astrazeneca Business Overview

Table 106. Astrazeneca Personalized Cancer Medicine Product

Table 107. Astrazeneca Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 108. Astrazeneca Recent Developments

Table 109. Johnson & Johnson Company Details

Table 110. Johnson & Johnson Business Overview

Table 111. Johnson & Johnson Personalized Cancer Medicine Product

Table 112. Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 113. Johnson & Johnson Recent Developments

Table 114. Agilent Company Details

Table 115. Agilent Business Overview

Table 116. Agilent Personalized Cancer Medicine Product

Table 117. Agilent Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 118. Agilent Recent Developments

Table 119. Takeda Company Details

Table 120. Takeda Business Overview

Table 121. Takeda Personalized Cancer Medicine Product

Table 122. Takeda Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 123. Takeda Recent Developments

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Personalized Cancer Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Personalized Cancer Medicine Market Share by Type: 2023 VS 2030

Figure 3. Monoclonal Antibodies Features

Figure 4. Personalized Cancer Vaccines Features

Figure 5. Other Features

Figure 6. Global Personalized Cancer Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Personalized Cancer Medicine Market Share by Application: 2023 VS 2030

Figure 8. Breast Cancer Case Studies

Figure 9. Lung Cancer Case Studies

Figure 10. Chronic Myeloid Leukaemia Case Studies

Figure 11. Bowel Cancer Case Studies

Figure 12. Other Cancer Case Studies

Figure 13. Personalized Cancer Medicine Report Years Considered

Figure 14. Global Personalized Cancer Medicine Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Personalized Cancer Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Personalized Cancer Medicine Market Share by Region: 2023 VS 2030

Figure 17. Global Personalized Cancer Medicine Market Share by Players in 2023

Figure 18. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Personalized Cancer Medicine Revenue in 2023

Figure 20. North America Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Personalized Cancer Medicine Market Share by Type (2019-2030)

Figure 22. North America Personalized Cancer Medicine Market Share by Application (2019-2030)

Figure 23. North America Personalized Cancer Medicine Market Share by Country (2019-2030)

Figure 24. United States Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Personalized Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe Personalized Cancer Medicine Market Share by Type (2019-2030)

Figure 28. Europe Personalized Cancer Medicine Market Share by Application (2019-2030)

Figure 29. Europe Personalized Cancer Medicine Market Share by Country (2019-2030)

Figure 30. Germany Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Personalized Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China Personalized Cancer Medicine Market Share by Type (2019-2030)

Figure 38. China Personalized Cancer Medicine Market Share by Application (2019-2030)

Figure 39. Asia Personalized Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia Personalized Cancer Medicine Market Share by Type (2019-2030)

Figure 41. Asia Personalized Cancer Medicine Market Share by Application (2019-2030)

Figure 42. Asia Personalized Cancer Medicine Market Share by Region (2019-2030)

Figure 43. Japan Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Personalized Cancer Medicine Market Share by Country (2019-2030)

Figure 53. Brazil Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Abbott Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 60. Merck Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 61. Novartis Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 62. Amgen Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 63. Celgene Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 64. Bayer Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 65. Roche Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 66. Astellas Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 67. Astrazeneca Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 68. Johnson & Johnson Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 69. Agilent Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 70. Takeda Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Personalized Cancer Medicine Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-11F3068

Tue Dec 31 00:00:00 UTC 2024

Add to Cart

Global Radiotherapy Machines Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-35N14554

Tue Dec 31 00:00:00 UTC 2024

Add to Cart

Global Biliary Tumor Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-37Y919

Tue Dec 31 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Tue Dec 31 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions